ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Colorectal Cancer
This article is part of the Research TopicArtificial Intelligence in Immunotherapy for Gastrointestinal Cancers: From Prediction to Precision MedicineView all 7 articles
Association Between Pre-Reversal Systemic Inflammation Response Index and Low Anterior Resection Syndrome in Rectal Cancer Patients: A Retrospective Cohort Study
Provisionally accepted
- The Fourth Hospital of Heibei Medical University, Shijiazhuang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose: This study aims to explore the relationship between the systemic inflammation response index (SIRI) and the development of low anterior resection syndrome (LARS) in rectal cancer patients after ileostomy closure. Methods: This retrospective cohort study included 116 rectal cancer patients who underwent low anterior resection with diverting ileostomy and subsequent ileostomy reversal at the Fourth Hospital of Hebei Medical University between August 2022 and April 2024. SIRI was calculated from complete blood counts obtained within 1 week prior to ileostomy reversal. Postoperative bowel function was evaluated using the validated LARS questionnaire at 12 months after ileostomy closure. The association between SIRI and major LARS was examined using multivariable logistic regression models. A spline-based smooth curve fitting approach was applied to assess potential nonlinearity, and subgroup analyses were performed to explore effect modification across clinically relevant strata. Results: Among the 116 patients, 47 (40.5%) developed major LARS, while 69 (59.5%) had no or minor LARS. Compared to the no/minor LARS group, the major LARS group showed significantly higher SIRI levels (P = 0.011). Multivariate logistic regression analysis indicated that elevated SIRI was associated with a 295% increased risk of major LARS (OR: 3.95; 95% CI: 1.24, 12.61; P = 0.020). Subgroup analysis revealed that this association was more pronounced in patients with a lower anastomotic height (≤4 cm), younger age (≤60 years), shorter interval to stoma closure (Tertile 1), and those who did not receive adjuvant therapy. Conclusion: SIRI may become a biomarker for identifying patients at higher risk of developing severe LARS after rectal cancer surgery. Integrating SIRI into preoperative assessments could allow for early intervention and personalized management strategies to mitigate the severity of LARS.
Keywords: Bowel dysfunction, Low anterior resection syndrome, Preventive stoma, rectal cancer, systemic inflammation response index
Received: 24 Sep 2025; Accepted: 03 Feb 2026.
Copyright: © 2026 Zhang, Qingyu, Wang, Jiang, Tian, Fan, Wang and Niu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wenbo Niu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.